Minor restorations decreased after implementation of sugar sweetened beverage tax
Meeting Announcement
A study aiming to examine rates of minor restorations before and after the implementation of a Sugar Sweetened Beverage (SSB) tax in the city of Boulder, Colorado, on July 1, 2017 was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research.
A study aiming to synthesize a three-dimensional (3D) printing resin with good mechanical properties, low cytotoxicity, antibacterial activities, and long-term fluoride-releasing properties was presented at the 102nd General Session of the IADR, which was held in conjunction with the 53rd Annual Meeting of the American Association for Dental, Oral, and Craniofacial Research and the 48th Annual Meeting of the Canadian Association for Dental Research, on March 13-16, 2024, in New Orleans, LA, USA.
The Regenerative Manufacturing Innovation Consortium (RegMIC), a leading organization focused on advancing the field of regenerative medicine, today announced its annual meeting, scheduled for May 15, 2024, at the DoubleTree by Hilton Charlotte Airport.
Dr. James McCully of Harvard Medical School and Boston Children's Hospital, USA, invited by Dr. Marvin Edeas, from Institut Cochin, Université Paris Cité, France, will host an instructive discussion on Mitochondrial Transplantation.
This collaboration with the World Mitochondria Society (WMS) promises an insightful presentation by Dr. McCully on the topic of "Mitochondrial Transplantation: Rescue of Cellular Viability and Function and Modulation of the Ischemic Phenotype in the Myocardium." Dr. McCully will present the role of mitochondrial transplantation in enhancing outcomes for myocardial ischemia/reperfusion injury and its profound impact on the transcriptomic profile.
Researchers available for interview about their new studies and other women’s health topics
London, UK, 15 March 2024. Serac Healthcare Limited (“Serac Healthcare” or “the Company”), a clinical radiopharmaceutical company developing an innovative molecular imaging agent, and the Nuffield Department of Women’s and Reproductive Health at the University of Oxford announce that preliminary data has been presented from the “Detecting Endometriosis expressed integrins using technetium-99m” (DETECT) imaging study, indicating that 99mTc-maraciclatide is capable of imaging superficial peritoneal endometriosis, the earliest stage of the disease. The data was presented today by Dr Tatjana Gibbons, an investigator on the study from the University of Oxford, in an oral presentation at the Society for Reproductive Investigation (SRI) annual meeting taking place from 12-16 March 2024 in Vancouver, Canada.
Discover the hottest science in the prevention and treatment of heart rhythm disorders at EHRA 2024, a scientific congress of the European Society of Cardiology (ESC). The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held 7 to 9 April at the CityCube Berlin, Germany, and online. Explore the scientific programme.
The 15th International Conference on Skin Ageing & Challenges is set to convene from November 7 to 8, 2024, at the Corinthia Palace in Malta. Researchers, scientists, and industry professionals will gather to explore the latest advancements and future prospects in skin ageing research.
Extreme heat, prolonged drought or too much rain: Europe's landscapes have suffered from a variety of extreme events in recent years. Floods and droughts have caused considerable damage, not only to nature but also to society. To counteract such acute events, the SpongeBoost project was launched in January 2024. It aims to tackle these severe circumstances by protecting and promoting natural sponge landscapes. Funded by the European Union’s Horizon Europe research and innovation programme, the four-year endeavour is coordinated by the Helmholtz Centre for Environmental Reseach (UFZ) and will be developed with thee active participation of 10 partnering institutions from 7 countries across Europe.
The International Society of Microbiota (ISM) announces its 11th World Congress, "Targeting Microbiota 2024", scheduled for October 14-15 at the Corinthia Palace in Malta. This event is set to highlight the latest research and developments in microbiotal medicine, emphasizing its impact on human health and its potential in shaping future medical treatment approaches.
LOS ANGELES — Researchers with City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new findings at the AACR Annual Meeting, which will take place April 5 to 10 in San Diego.
The World Mitochondria Society is pleased to announce the agenda and the initial list of speakers for Targeting Mitochondria 2024. This event is scheduled from October 29th to 31st, 2024, at the DoubleTree by Hilton Berlin Ku’damm.
Innovative Approaches at Targeting Mitochondria 2024
Volkmar Weissig, the society's president, and Marvin Edeas, founder and chairman of the Scientific Board, are gearing up to guide Targeting Mitochondria 2024 toward groundbreaking and non-traditional strategies. They emphasize the conference's focus on "Emerging Trends and Strategies in Mitochondrial Research."